I read with interest the article by Corrà and associates 1 that appeared in a recent Circulation issue. In 133 chronic heart failure patients, the authors elegantly demonstrated that those (nϭ22) who exhibit both central sleep apnea (CSA; apnea/ hypopnea index Ն30) and exercise oscillatory ventilation (EOV) have a very unfavorable prognosis. The negative survival expectation is, however, primarily driven by CSA, a recognized prognostic marker, rather than by EOV, a disorder found to be prognostic irrespective of CSA coexistence. 2 Accordingly, patients with isolated EOV had clinical data and survival rates similar to those without oscillatory kinetics. This observation suggests that EOV may not hold clinical importance and weakens the argument for interdependent pathways in the genesis of EOV and CSA. As an overall comment, any reasoning on this category of patients is likely flawed by the small number of subjects investigated (nϭ6). This is the first study in which EOV was tested against exercise V E/V CO 2 slope, a powerful prognosticator in chronic heart failure patients with intermediate performance. 3 Statistical comparison is not reported, and at the multivariate Cox analysis, CSA, peak V O 2 , and ␤-blocker therapy emerged as prognostic, whereas V E/V CO 2 slope, in contrast with established evidence, did not. The information may be misleading in some instances and can be explained by technical difficulties related to the calculation of V E/V CO 2 slope in the setting of oscillatory gas kinetics, including the definition of its linear relationship from the beginning of exercise to the isocapnic compensatory point. The concern is strengthened by the discrepancies among the few studies available. In 25 similar patients, Leite et al 2 reported an average V E/V CO 2 slope of 48.7, which is similar to the 46.6 reported in another study involving 10 patients. 4 Both studies appear far from the V E/V CO 2 slopes of 30 (EOV alone) and 40 (CSA and EOV) reported by Corrà et al.
